Silk Therapeutics, Inc. is a Boston-based startup that specializes in harnessing real silk protein for human health and wellness, offering a line of skincare products under the name Silk Therapeutics. The company's products are known for their clean and highly effective anti-aging properties, suitable for all skin types, including highly sensitive skin.
Founded in 2013, Silk Therapeutics has carved a niche in the Biopharma, Biotechnology, Fashion, Health Care, Manufacturing, and Pharmaceutical industries. Their proprietary liquid silk technology, developed by co-founders Greg Altman, PhD and Rebecca Horan, PhD, enables the stabilization and delivery of real silk molecules to the skin.
In its most recent funding round in October 2018, the company secured a $30.00M Series B investment from notable investors The Kraft Group and Roy P. Disney. Additionally, Silk Therapeutics operates Pure Silk Solutions, Inc., a subsidiary dedicated to the manufacture and supply of silk protein solutions to the research, medical, and technology communities.
With a focus on innovation and a strong investor backing, Silk Therapeutics is poised to continue its pioneering work in the application of silk for health and wellness solutions, making a significant impact in multiple industries.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series B | $30.00M | 2 |
|
24 Oct 2018 |
| Series A | $11.00M | 6 |
|
28 Sep 2017 |
| Series A | $6.00M | 2 |
|
03 Feb 2016 |
| Series A | $3.00M | - | 05 May 2015 | |
| Venture Round | $1.39M | - | 29 Aug 2014 |
No recent news or press coverage available for Silk Therapeutics, Inc..
We care about your data, and we'd love to use cookies make your experience better.